Sangamo Therapeutics
SGMO
#8725
Rank
โ‚ฌ0.14 B
Marketcap
0,43ย โ‚ฌ
Share price
-6.45%
Change (1 day)
-77.11%
Change (1 year)

Sangamo Therapeutics (SGMO) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚ฌ5.36 Million

According to Sangamo Therapeutics 's latest financial reports the company has โ‚ฌ5.36 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sangamo Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$โ‚ฌ21.88 M-70.82%
2023-12-31$โ‚ฌ74.97 M-72.73%
2022-12-31$โ‚ฌ0.27 B-17.03%
2021-12-31$โ‚ฌ0.33 B-18.04%
2020-12-31$โ‚ฌ0.40 B4.68%
2019-12-31$โ‚ฌ0.38 B20.33%
2018-12-31$โ‚ฌ0.32 B105%
2017-12-31$โ‚ฌ0.15 B20.95%
2016-12-31$โ‚ฌ0.12 B-26.43%
2015-12-31$โ‚ฌ0.17 B3.59%
2014-12-31$โ‚ฌ0.16 B92.78%
2013-12-31$โ‚ฌ88.13 M79.64%
2012-12-31$โ‚ฌ49.06 M-20.49%
2011-12-31$โ‚ฌ61.7 M46.8%
2010-12-31$โ‚ฌ42.03 M-16.11%
2009-12-31$โ‚ฌ50.1 M26.44%
2008-12-31$โ‚ฌ39.62 M-19.78%
2007-12-31$โ‚ฌ49.39 M33.82%
2006-12-31$โ‚ฌ36.91 M15.63%
2005-12-31$โ‚ฌ31.92 M33.74%
2004-12-31$โ‚ฌ23.86 M-32.72%
2003-12-31$โ‚ฌ35.47 M-31.64%
2002-12-31$โ‚ฌ51.89 M-44.35%
2001-12-31$โ‚ฌ93.24 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
โ‚ฌ18.42 B 343,580.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ0.20 B 3,646.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ8.26 B 153,976.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ15.63 B 291,546.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
โ‚ฌ16.37 B 305,266.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ68.09 B 1,269,754.24%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ5.20 B 96,916.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ44.58 B 831,343.22%๐Ÿ‡บ๐Ÿ‡ธ USA